These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16088968)

  • 21. The use of a physiologically based pharmacokinetic model to evaluate deconvolution measurements of systemic absorption.
    Levitt DG
    BMC Clin Pharmacol; 2003 Mar; 3():1. PubMed ID: 12659643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two constrained deconvolution methods using spline functions.
    Verotta D
    J Pharmacokinet Biopharm; 1993 Oct; 21(5):609-36. PubMed ID: 8145134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the unphysical hypotheses in pharmacokinetics and oral drug absorption: Time to utilize instantaneous rate coefficients instead of rate constants.
    Mavroudis PD; Kosmidis K; Macheras P
    Eur J Pharm Sci; 2019 Mar; 130():137-146. PubMed ID: 30690188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DeMonS--a new deconvolution method for estimating drug absorbed at different time intervals and/or drug disposition model parameters using a monotonic cubic spline.
    Yu Z; Hwang SS; Gupta SK
    Biopharm Drug Dispos; 1997 Aug; 18(6):475-87. PubMed ID: 9267681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deconvolution method for assessing the absorption of a drug with reversible metabolic pathways.
    Hwang S; Knowles M
    J Pharm Sci; 1994 May; 83(5):629-31. PubMed ID: 8071809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Advances and related issues in the use of in vitro methods to predict metabolic clearance rate of new drugs].
    Zhang Q; Wang GJ
    Yao Xue Xue Bao; 2007 Oct; 42(10):1023-8. PubMed ID: 18229605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application of numerical convolution in in vivo/in vitro correlation research].
    Yue P
    Yao Xue Xue Bao; 2009 Jan; 44(1):19-24. PubMed ID: 19350816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug absorption: a practical method to estimate the absorption rate constant.
    Lambert C; du Souich P
    Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):217-29. PubMed ID: 7335952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of input functions in rodents: challenges and solutions.
    Laforest R; Sharp TL; Engelbach JA; Fettig NM; Herrero P; Kim J; Lewis JS; Rowland DJ; Tai YC; Welch MJ
    Nucl Med Biol; 2005 Oct; 32(7):679-85. PubMed ID: 16243642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism-based inhibition of cytochrome P450 enzymes: an evaluation of early decision making in vitro approaches and drug-drug interaction prediction methods.
    Grime KH; Bird J; Ferguson D; Riley RJ
    Eur J Pharm Sci; 2009 Feb; 36(2-3):175-91. PubMed ID: 19013237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview of computer algorithms for deconvolution-based assessment of in vivo neuroendocrine secretory events.
    Veldhuis JD; Johnson ML
    Biotechniques; 1990 Jun; 8(6):634-9. PubMed ID: 2192741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Model-independent method of analyzing input in linear pharmacokinetic systems having polyexponential impulse response II: Numerical evaluation.
    Pedersen PV
    J Pharm Sci; 1980 Mar; 69(3):305-12. PubMed ID: 7381707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applications of physiologically based absorption models in drug discovery and development.
    Parrott N; Lave T
    Mol Pharm; 2008; 5(5):760-75. PubMed ID: 18547054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced parameter estimation methods for noisy SPECT data.
    Wen L; Eberl S; Choi HC; Feng DD; Fulham M
    Comput Methods Programs Biomed; 2008 Feb; 89(2):102-11. PubMed ID: 17502121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative performance of different stochastic methods to simulate drug exposure and variability in a population.
    Tam VH; Kabbara S
    Diagn Microbiol Infect Dis; 2006 Oct; 56(2):185-8. PubMed ID: 16930922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the nonparametric estimation method in NONMEM VI.
    Savic RM; Kjellsson MC; Karlsson MO
    Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling.
    Gibson CR; Bergman A; Lu P; Kesisoglou F; Denney WS; Mulrooney E
    Xenobiotica; 2009 Sep; 39(9):637-48. PubMed ID: 19480559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An algorithm for constrained deconvolution based on reparameterization.
    Veng-Pedersen P; Modi NB
    J Pharm Sci; 1992 Feb; 81(2):175-80. PubMed ID: 1545358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.